Open Doors for Business in Scotland

Since the outcome of the Scottish referendum held in September, ABPI Scotland, which represents the research-based pharmaceutical industry in the UK, has made it clear that business is open as usual and is looking forward to working with all stakeholders to ensure that patients in Scotland get greater, more rapid access to new medicines and that the research and business environment supports the growth of the critical medicines sector.

Andrew Powrie-Smith, Director of ABPI Scotland said: “The pharmaceutical sector in Scotland is already the single largest contributor to Scottish industrial R&D and is the largest of all Scotland’s life sciences sectors. It is a unique industry that researches and develops cutting-edge, life-saving medicines while at the same time making such a valuable contribution to the economy. Given the right commercial environment, the sector can continue to be at the cutting edge of Scotland’s science-based economy.

“ABPI will continue to work with all stakeholders to ensure that Scotland has the best possible business and research environment as well as access to the latest, most innovative medicines for Scottish patients.”